Gauhati Medical College selected for COVAXIN 2nd phase clinical testing
The Gauhati Medical College and Hospital
(GMCH) has been selected for the second phase clinical testing of India's
indigenously developed coronavirus vaccine, COVAXIN, Assam
Health Minister Himanta Biswa Sarma said on Tuesday.
He said the GMCH would provide all-out
support for the second phase clinical testing of COVAXIN, which has already
shown successful results in phase-one clinical trials.
According to the Minister, till Tuesday
night, Assam has tested more than 18.22 lakh samples with 79,667 people testing
positive for Covid-19. Of the total cases, 56,734 people have recovered from
the disease with the recovery rate being 71.2 per cent and mortality rate 0.25
per cent. Read More
Comments
Post a Comment